We are live on ! Find out more
CAM

Cypress Asset Management Portfolio holdings

AUM $455M
1-Year Est. Return 26.87%
This Fund
S&P 500
This Quarter Est. Return
+12.03%
1 Year Est. Return
+26.87%
3 Year Est. Return
+113.59%
5 Year Est. Return
+132.49%
10 Year Est. Return
+426.19%
AUM
$420M
AUM Growth
+$34.4M
Cap. Flow
-$3.95M
Cap. Flow %
-0.94%
Top 10 Hldgs %
31.5%
Holding
139
New
5
Increased
18
Reduced
101
Closed
2

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$1.06M
2
ASML icon
ASML
ASML
+$675K
3
PFE icon
Pfizer
PFE
+$260K
4
AMZN icon
Amazon
AMZN
+$233K
5
LRCX icon
Lam Research
LRCX
+$204K

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$773K
2
BABA icon
Alibaba
BABA
+$609K
3
BMY icon
Bristol-Myers Squibb
BMY
+$485K
4
AMGN icon
Amgen
AMGN
+$473K
5
VZ icon
Verizon
VZ
+$270K

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Healthcare 14.81%
3 Consumer Discretionary 14%
4 Financials 13.65%
5 Consumer Staples 11.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
26
Honeywell
HON
$77B
$5.39M 1.28%
27,411
+208
+0.8% +$42K
ADBE icon
27
Adobe
ADBE
$99.5B
$5.04M 1.2%
8,880
-217
-2% -$136K
UNH icon
28
UnitedHealth
UNH
$376B
$4.57M 1.09%
9,098
-33
-0.4% -$14.9K
AMAT icon
29
Applied Materials
AMAT
$403B
$4.43M 1.05%
28,160
+107
+0.4% +$15.5K
UPS icon
30
United Parcel Service
UPS
$88.6B
$4.3M 1.02%
20,061
-76
-0.4% -$15.5K
NKE icon
31
Nike
NKE
$61.9B
$4.27M 1.02%
25,595
-214
-0.8% -$35.3K
LMT icon
32
Lockheed Martin
LMT
$134B
$4.24M 1.01%
11,934
-497
-4% -$172K
ABT icon
33
Abbott
ABT
$183B
$4.23M 1.01%
30,072
-143
-0.5% -$18.3K
CL icon
34
Colgate-Palmolive
CL
$73.1B
$4.1M 0.97%
47,993
-592
-1% -$46.2K
MRK icon
35
Merck
MRK
$322B
$4.06M 0.97%
52,917
-1,716
-3% -$137K
ZTS icon
36
Zoetis
ZTS
$32.4B
$4.04M 0.96%
16,565
-565
-3% -$124K
STZ icon
37
Constellation Brands
STZ
$22.2B
$4.04M 0.96%
16,099
-266
-2% -$60.6K
LIN icon
38
Linde
LIN
$221B
$3.92M 0.93%
11,310
+150
+1% +$48.6K
PNC icon
39
PNC Financial Services
PNC
$99.7B
$3.9M 0.93%
19,436
-65
-0.3% -$13.2K
MDT icon
40
Medtronic
MDT
$109B
$3.4M 0.81%
32,891
-129
-0.4% -$14.9K
PFE icon
41
Pfizer
PFE
$143B
$3.29M 0.78%
55,700
+5,252
+10% +$260K
INTC icon
42
Intel
INTC
$455B
$3.27M 0.78%
63,469
-1,246
-2% -$63.7K
MMM icon
43
3M
MMM
$90.9B
$3.12M 0.74%
21,013
-633
-3% -$94.3K
DIS icon
44
Walt Disney
DIS
$167B
$3.08M 0.73%
19,913
+74
+0.4% +$12K
KO icon
45
Coca-Cola
KO
$377B
$3.04M 0.72%
51,252
-1,573
-3% -$87.6K
BLK icon
46
Blackrock
BLK
$169B
$2.81M 0.67%
3,066
IHI icon
47
iShares US Medical Devices ETF
IHI
$3.13B
$2.8M 0.67%
42,485
-1,855
-4% -$119K
RTX icon
48
RTX Corp
RTX
$290B
$2.77M 0.66%
32,200
+40
+0.1% +$3.48K
CRM icon
49
Salesforce
CRM
$151B
$2.74M 0.65%
10,786
-160
-1% -$45K
TSM icon
50
TSMC
TSM
$2.1T
$2.73M 0.65%
22,710
-206
-0.9% -$24.1K

Similar funds

Cypress Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Cypress Asset Management held 139 positions worth $420M, up 8.9% from $386M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Cypress Asset Management's Q4 2021 filing shows 5 new, 18 increased, 101 reduced and 2 closed positions. Its largest new stake was ASML: 850 shares worth $677K. The largest sale was Teladoc Health, an estimated $773K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Cypress Asset Management's largest Q4 2021 buy was ASML: 850 shares worth $677K.
  • Cypress Asset Management added most to Goldman Sachs in Q4 2021, an estimated $1.06M increase.
  • Cypress Asset Management's biggest Q4 2021 reduction was Alibaba, cutting an estimated $609K.
  • Cypress Asset Management fully exited Teladoc Health in Q4 2021, selling an estimated $773K.
  • Cypress Asset Management's ten largest holdings make up 32% of its $420M portfolio in Q4 2021.
  • Cypress Asset Management opened 5 new positions and closed 2 in Q4 2021.
  • Cypress Asset Management's portfolio value rose 8.9% quarter-over-quarter to $420M.

Based on Cypress Asset Management's 13F filing for Q4 2021, filed 31 Jan 2022.